SEC Tracker
Get the app

Organon OGN

Organon released Q3 2026 results

Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Routine
  1. Q3 2026 financial results released
  2. Non-GAAP metrics included in Exhibit 99.1
  3. No earnings press release due to merger

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Organon files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cytokinetics CYTK public float $2.5B, Jun 30, 2025
  2. TG Therapeutics TGTX public float $2.5B, Jun 30, 2025
  3. Catalyst Pharmaceuticals CPRX public float $2.5B, Jun 30, 2025
  4. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  5. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.